BeLeaf Medical CEO Jason Nelson At Benzinga Cannabis Capital Conference Says At Every Level Of That Regulatory Function Into That Point, Local Municipalities Can Change Over Time
Portfolio Pulse from Benzinga Newsdesk
BeLeaf Medical CEO Jason Nelson spoke at the Benzinga Cannabis Capital Conference, discussing the changing nature of local regulatory functions in the cannabis industry.
September 27, 2023 | 8:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
The discussion by BeLeaf Medical's CEO at the Benzinga Cannabis Capital Conference may indirectly affect MSOS, an ETF that tracks the performance of US-listed cannabis companies.
While MSOS was not directly mentioned, the ETF could be indirectly affected by changes in the regulatory landscape of the cannabis industry discussed by BeLeaf Medical's CEO. However, the exact impact is uncertain due to the indirect nature of the connection.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50